ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis: Taiwan Tuesday, January 6, 2026, 14:00 Hrs [IST] ScinoPharm Taiwan, a professiona ...
10hon MSNOpinion
A New Kind of Security Risk Is Emerging. Take These 3 Steps to Protect Your Business.
As connected products blur the line between digital vulnerabilities and physical safety, manufacturers must make a ...
The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.
Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...
This article explores the US and EU compliance requirements to ensure patient safety for GMP ancillary materials in cell and ...
Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...
Term Sheet readers sounded off on how they think the state of exits in the private markets will evolve through 2026.
ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Glatiramer Acetate Injection ...
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch ...
ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food ...
India’s rising market concentration and regulatory friction increasingly favour large firms, making it harder for small ...
The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback